New York State Common Retirement Fund Prelude Therapeutics Inc Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 3,622 shares of PRLD stock, worth $2,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,622
Previous 3,622
-0.0%
Holding current value
$2,571
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
30.4MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$7.75 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$7.19 Million0.14% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$758,9300.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$730,7310.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$717,3780.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $25.8M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...